Table 1.

Vasopermeability and cytokine activity of chTNT-3/IL-2 WT and IL-2 analog fusion proteins


Molecule

Vasopermeability, % ± SD

HT-2 proliferation*
chTNT-3   0 ± 5   —  
chTNT-3/IL-2 WT   100 ± 15   ++++  
chTNT-3/Asp20Lys   -28 ± 6   —  
chTNT-3/Arg38Gly   -7 ± 15   +  
chTNT-3/Arg38Trp   4 ± 16   +++  
chTNT-3/Arg38Glu   -5 ± 6   —  
chTNT-3/Arg38Tyr   42 ± 8   ++  
chTNT-3/Met39Val   99 ± 27   +  
chTNT-3/Met39Leu   52 ± 23   +  
chTNT-3/Phe42Lys   97 ± 31   +  
chTNT-3/His55Tyr   -6 ± 6   +  
chTNT-3/Asn8Arg
 
98 ± 4
 
+++
 

Molecule

Vasopermeability, % ± SD

HT-2 proliferation*
chTNT-3   0 ± 5   —  
chTNT-3/IL-2 WT   100 ± 15   ++++  
chTNT-3/Asp20Lys   -28 ± 6   —  
chTNT-3/Arg38Gly   -7 ± 15   +  
chTNT-3/Arg38Trp   4 ± 16   +++  
chTNT-3/Arg38Glu   -5 ± 6   —  
chTNT-3/Arg38Tyr   42 ± 8   ++  
chTNT-3/Met39Val   99 ± 27   +  
chTNT-3/Met39Leu   52 ± 23   +  
chTNT-3/Phe42Lys   97 ± 31   +  
chTNT-3/His55Tyr   -6 ± 6   +  
chTNT-3/Asn8Arg
 
98 ± 4
 
+++
 
*

Stimulation of HT-2 proliferation expressed as percentage of wild-type activity: — indicates no activity, +, less than 25% activity, ++, 25%-50% activity, +++, 50%-75% activity, ++++, 75%-100%.

Close Modal

or Create an Account

Close Modal
Close Modal